SOPHiA GENETICS

SOPHiA GENETICS is at the forefront of biotechnology research, dedicated to democratizing data-driven medicine. With a revolutionary technology platform, SOPHiA DDM™, the company rapidly distills complex data into actionable insights. This empowers clinicians, researchers, and biopharma to reshape the diagnosis and treatment of cancer and rare inherited disorders.

Driven by a mission to transform patient care, SOPHiA GENETICS utilizes the power of data and AI to expand access to data-driven medicine globally. The AI fueling the platform learns from complex genomic and multimodal data, creating a collective intelligence over time. The primary address of SOPHiA GENETICS is La Pièce 12, Rolle, 1180, CH. Additionally, they have locations at 185 Dartmouth St, Floor 5, Boston, Massachusetts 02116, US, and Technopole Izarbel 158 allée Fauste d’Elhuyar, Bidart, 64210, FR.

SOPHiA GENETICS is committed to ensuring that every patient worldwide has equitable access to precision medicine. This commitment is reflected in their unwavering passion for science and their dedication to making a positive and lasting impact on the world. We invite the manager of SOPHiA GENETICS to create a customized and exclusive company showcase and product listing on our platform to further enhance their reach and impact.